All
The Weekly Roundup: February 12-16
February 17th 2024ICYMI, this week we had news about the National Rosacea Society's Seal of Acceptance Program, Dermavant's submitted sNDA for tapinarof cream 1% to treat AD, Galderma's accepted BLA for nemolizumab for the treatment of prurigo nodularis and AD, and more.
Mike Siegel, PhD: What's Coming Up in 2024 for PeDRA
February 16th 2024In an interview with Dermatology Times, the executive director of Pediatric Dermatology Research Alliance (PeDRA) discusses the group's growth since 2012 and what it can offer practicing dermatologists, researchers, students, and patients.
Previewing Editorial Advisory Board Member Sessions at Winter Clinical Miami 2024
February 15th 2024Among the many sessions to be held at the Winter Clinical Miami 2024 Conference in Miami Beach, Florida, several Dermatology Times Editorial Advisory Board members are preparing to share their knowledge and insights.